Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)
Clinical trial NCT00686829 · COMPLETED
Trial details
- NCT number
- NCT00686829
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-30
- Primary completion
- 2010-10-21
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.